Skip to main content
Top
Published in: European Journal of Nutrition 3/2014

01-04-2014 | Original Contribution

Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency

Authors: Jesse Bertinato, Cristina Aroche, Louise J. Plouffe, Megan Lee, Zehra Murtaza, Laura Kenney, Christopher Lavergne, Alfred Aziz

Published in: European Journal of Nutrition | Issue 3/2014

Login to get access

Abstract

Purpose

Since obesity is associated with poorer iron status, the effects of diet-induced obesity on iron status and iron-regulatory pathways were examined.

Methods

Weanling male diet-induced obese sensitive (n = 12/diet group) and resistant (n = 12/diet group) rats were fed one of four high-fat, high-energy diets supplemented with 5 (5Fe, low), 15 (15Fe, marginal), 35 (35Fe, normal) or 70 (70Fe, high) mg iron/kg diet for 12 weeks. At the end of the study, rats in each diet group were categorised as obese (>19 %) or lean (<17 %) based on percentage body fat.

Results

Obese rats gained more weight, had larger total lean mass, consumed more food and showed greater feed efficiency compared with lean rats. Obese rats fed the 5Fe and 15Fe diets had poorer iron status than lean rats fed the same diet. Obese 5Fe rats had lower serum iron and more severe iron-deficiency anaemia. Obese 15Fe rats had lower mean corpuscular haemoglobin and liver iron concentrations. Hepcidin mRNA expression in liver and adipose tissue was similar for obese and lean rats. Iron concentration and content of the iron transporters divalent metal transporter 1 and ferroportin 1 in duodenal mucosa were also similar.

Conclusions

Obese rats that were larger, regardless of adiposity, had higher iron requirements compared with lean rats that appeared independent of hepcidin, inflammation and intestinal iron absorption. Higher iron requirements may have resulted from larger accretion of body mass and blood volume. Greater food consumption did not compensate for the higher iron needs, indicating increased susceptibility to iron deficiency.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stoltzfus R (2001) Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr 131(2S-2):565S–567S Stoltzfus R (2001) Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr 131(2S-2):565S–567S
2.
go back to reference Zimmermann MB, Hurrell RF (2007) Nutritional iron deficiency. Lancet 370(9586):511–520CrossRef Zimmermann MB, Hurrell RF (2007) Nutritional iron deficiency. Lancet 370(9586):511–520CrossRef
3.
go back to reference Brownlie T 4th, Utermohlen V, Hinton PS, Giordano C, Haas JD (2002) Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 75(4):734–742 Brownlie T 4th, Utermohlen V, Hinton PS, Giordano C, Haas JD (2002) Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 75(4):734–742
4.
go back to reference Brownlie T 4th, Utermohlen V, Hinton PS, Haas JD (2004) Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 79(3):437–443 Brownlie T 4th, Utermohlen V, Hinton PS, Haas JD (2004) Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 79(3):437–443
5.
go back to reference Gardner GW, Edgerton VR, Senewiratne B, Barnard RJ, Ohira Y (1977) Physical work capacity and metabolic stress in subjects with iron deficiency anemia. Am J Clin Nutr 30(6):910–917 Gardner GW, Edgerton VR, Senewiratne B, Barnard RJ, Ohira Y (1977) Physical work capacity and metabolic stress in subjects with iron deficiency anemia. Am J Clin Nutr 30(6):910–917
6.
go back to reference Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85(3):778–787 Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85(3):778–787
7.
go back to reference Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M (2004) Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114(1):104–108CrossRef Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M (2004) Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114(1):104–108CrossRef
8.
go back to reference Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M (2003) Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27(3):416–418CrossRef Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M (2003) Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27(3):416–418CrossRef
9.
go back to reference Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J (2006) Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) 14(10):1724–1730CrossRef Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J (2006) Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) 14(10):1724–1730CrossRef
10.
go back to reference Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT et al (2007) Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 31(9):1412–1419CrossRef Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT et al (2007) Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 31(9):1412–1419CrossRef
11.
go back to reference Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al (2008) Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 108(1):145–148CrossRef Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al (2008) Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 108(1):145–148CrossRef
12.
go back to reference Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F, Feskens E et al (2011) Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 93(5):975–983CrossRef Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F, Feskens E et al (2011) Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 93(5):975–983CrossRef
13.
go back to reference McClung JP, Karl JP (2009) Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 67(2):100–104CrossRef McClung JP, Karl JP (2009) Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 67(2):100–104CrossRef
14.
go back to reference Zafon C, Lecube A, Simo R (2010) Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev 11(4):322–328CrossRef Zafon C, Lecube A, Simo R (2010) Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev 11(4):322–328CrossRef
15.
go back to reference Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434–1443CrossRef Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434–1443CrossRef
16.
go back to reference Ganz T (2012) Macrophages and systemic iron homeostasis. J Innate Immun 4(5–6):446–453CrossRef Ganz T (2012) Macrophages and systemic iron homeostasis. J Innate Immun 4(5–6):446–453CrossRef
17.
go back to reference Sonnweber T, Ress C, Nairz M, Theurl I, Schroll A, Murphy AT et al (2012) High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem 23(12):1600–1608CrossRef Sonnweber T, Ress C, Nairz M, Theurl I, Schroll A, Murphy AT et al (2012) High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem 23(12):1600–1608CrossRef
18.
go back to reference Shields M, Carroll MD, Ogden CL (2011) Adult obesity prevalence in Canada and the United States. NCHS Data Brief 56(56):1–8 Shields M, Carroll MD, Ogden CL (2011) Adult obesity prevalence in Canada and the United States. NCHS Data Brief 56(56):1–8
19.
go back to reference Roberts KC, Shields M, de Groh M, Aziz A, Gilbert JA (2012) Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Rep 23(3):37–41 Roberts KC, Shields M, de Groh M, Aziz A, Gilbert JA (2012) Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Rep 23(3):37–41
20.
go back to reference Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123(11):1939–1951 Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123(11):1939–1951
21.
go back to reference Aziz AA, Kenney LS, Goulet B, Abdel-Aal ES (2009) Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. J Nutr 139(10):1881–1889CrossRef Aziz AA, Kenney LS, Goulet B, Abdel-Aal ES (2009) Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. J Nutr 139(10):1881–1889CrossRef
22.
go back to reference Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287(4):R943–R949CrossRef Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287(4):R943–R949CrossRef
23.
go back to reference Cockell KA, Fischer PW, Belonje B (1999) Elemental composition of anatomically distinct regions of rat liver. Biol Trace Elem Res 70(3):251–263CrossRef Cockell KA, Fischer PW, Belonje B (1999) Elemental composition of anatomically distinct regions of rat liver. Biol Trace Elem Res 70(3):251–263CrossRef
24.
go back to reference Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE (1997) Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 273(2 Pt 2):R725–R730 Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE (1997) Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 273(2 Pt 2):R725–R730
25.
go back to reference Farley C, Cook JA, Spar BD, Austin TM, Kowalski TJ (2003) Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res 11(7):845–851CrossRef Farley C, Cook JA, Spar BD, Austin TM, Kowalski TJ (2003) Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes Res 11(7):845–851CrossRef
26.
go back to reference Chang S, Graham B, Yakubu F, Lin D, Peters JC, Hill JO (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 259(6 Pt 2):R1103–R1110 Chang S, Graham B, Yakubu F, Lin D, Peters JC, Hill JO (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 259(6 Pt 2):R1103–R1110
27.
go back to reference Levin BE, Hogan S, Sullivan AC (1989) Initiation and perpetuation of obesity and obesity resistance in rats. Am J Physiol 256(3 Pt 2):R766–R771 Levin BE, Hogan S, Sullivan AC (1989) Initiation and perpetuation of obesity and obesity resistance in rats. Am J Physiol 256(3 Pt 2):R766–R771
28.
go back to reference Levin BE, Sullivan AC (1989) Glucose-induced sympathetic activation in obesity-prone and resistant rats. Int J Obes 13(2):235–246 Levin BE, Sullivan AC (1989) Glucose-induced sympathetic activation in obesity-prone and resistant rats. Int J Obes 13(2):235–246
29.
go back to reference Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C et al (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343(5):327–331CrossRef Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C et al (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343(5):327–331CrossRef
30.
go back to reference Knight GJ, Heese Hde V, Dempster WS, Kirsten G (1983) Diagnosis of iron deficiency: mean corpuscular hemoglobin (MCH) as a predictor of iron deficiency in infants. Pediatr Res 17(2):168–170CrossRef Knight GJ, Heese Hde V, Dempster WS, Kirsten G (1983) Diagnosis of iron deficiency: mean corpuscular hemoglobin (MCH) as a predictor of iron deficiency in infants. Pediatr Res 17(2):168–170CrossRef
31.
go back to reference Hunter JE (1978) Variable effects of iron status on the concentration of ferritin in rat plasma, liver, and spleen. J Nutr 108(3):497–505 Hunter JE (1978) Variable effects of iron status on the concentration of ferritin in rat plasma, liver, and spleen. J Nutr 108(3):497–505
32.
go back to reference Ward C, Saltman P, Ripley L, Ostrup R, Hegenauer J, Hatlen L et al (1977) Correlation of serum ferritin and liver ferritin iron in the anemic, normal, iron-loaded rat. Am J Clin Nutr 30(7):1054–1063 Ward C, Saltman P, Ripley L, Ostrup R, Hegenauer J, Hatlen L et al (1977) Correlation of serum ferritin and liver ferritin iron in the anemic, normal, iron-loaded rat. Am J Clin Nutr 30(7):1054–1063
33.
go back to reference Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P et al (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276(11):7811–7819CrossRef Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P et al (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276(11):7811–7819CrossRef
34.
go back to reference Flanagan JM, Truksa J, Peng H, Lee P, Beutler E (2007) In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol Dis 38(3):253–257CrossRef Flanagan JM, Truksa J, Peng H, Lee P, Beutler E (2007) In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol Dis 38(3):253–257CrossRef
35.
go back to reference Chung J, Kim MS, Han SN (2011) Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr Res 31(12):915–921CrossRef Chung J, Kim MS, Han SN (2011) Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr Res 31(12):915–921CrossRef
36.
go back to reference Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P et al (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480(2–3):147–150CrossRef Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P et al (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480(2–3):147–150CrossRef
37.
go back to reference Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276(11):7806–7810CrossRef Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276(11):7806–7810CrossRef
38.
go back to reference Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131(3):788–796CrossRef Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131(3):788–796CrossRef
39.
go back to reference Chung B, Matak P, McKie AT, Sharp P (2007) Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 137(11):2366–2370 Chung B, Matak P, McKie AT, Sharp P (2007) Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 137(11):2366–2370
40.
go back to reference Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102(3):783–788CrossRef Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102(3):783–788CrossRef
41.
go back to reference Baumgartner J, Smuts CM, Aeberli I, Malan L, Tjalsma H, Zimmermann MB (2013) Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention. Int J Obes (Lond) 37(1):24–30CrossRef Baumgartner J, Smuts CM, Aeberli I, Malan L, Tjalsma H, Zimmermann MB (2013) Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention. Int J Obes (Lond) 37(1):24–30CrossRef
42.
go back to reference Sanad M, Osman M, Gharib A (2011) Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr 37:34CrossRef Sanad M, Osman M, Gharib A (2011) Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr 37:34CrossRef
43.
go back to reference Cepeda-Lopez AC, Aeberli I, Zimmermann MB (2010) Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 80(4–5):263–270CrossRef Cepeda-Lopez AC, Aeberli I, Zimmermann MB (2010) Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 80(4–5):263–270CrossRef
44.
go back to reference Whittaker P, Mahoney AW, Hendricks DG (1984) Effect of iron-deficiency anemia on percent blood volume in growing rats. J Nutr 114(6):1137–1142 Whittaker P, Mahoney AW, Hendricks DG (1984) Effect of iron-deficiency anemia on percent blood volume in growing rats. J Nutr 114(6):1137–1142
45.
go back to reference Schreihofer AM, Hair CD, Stepp DW (2005) Reduced plasma volume and mesenteric vascular reactivity in obese zucker rats. Am J Physiol Regul Integr Comp Physiol 288(1):R253–R261CrossRef Schreihofer AM, Hair CD, Stepp DW (2005) Reduced plasma volume and mesenteric vascular reactivity in obese zucker rats. Am J Physiol Regul Integr Comp Physiol 288(1):R253–R261CrossRef
46.
go back to reference Astrup A (1996) Obesity and metabolic efficiency. Ciba Found Symp 201:159–193 Astrup A (1996) Obesity and metabolic efficiency. Ciba Found Symp 201:159–193
Metadata
Title
Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency
Authors
Jesse Bertinato
Cristina Aroche
Louise J. Plouffe
Megan Lee
Zehra Murtaza
Laura Kenney
Christopher Lavergne
Alfred Aziz
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 3/2014
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-013-0592-9

Other articles of this Issue 3/2014

European Journal of Nutrition 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.